KR20210073342A - Manufacturing method of plant-mixed beverage with antioxidant property and improved palatability and beverage produced by the same method - Google Patents
Manufacturing method of plant-mixed beverage with antioxidant property and improved palatability and beverage produced by the same method Download PDFInfo
- Publication number
- KR20210073342A KR20210073342A KR1020190164083A KR20190164083A KR20210073342A KR 20210073342 A KR20210073342 A KR 20210073342A KR 1020190164083 A KR1020190164083 A KR 1020190164083A KR 20190164083 A KR20190164083 A KR 20190164083A KR 20210073342 A KR20210073342 A KR 20210073342A
- Authority
- KR
- South Korea
- Prior art keywords
- concentrate
- weight
- beverage
- extract
- calamansi
- Prior art date
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 55
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 35
- 235000019629 palatability Nutrition 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 title claims abstract description 13
- 238000004519 manufacturing process Methods 0.000 title claims description 14
- 239000012141 concentrate Substances 0.000 claims abstract description 174
- 241000369096 Citrus x microcarpa Species 0.000 claims abstract description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 36
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 34
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims abstract description 31
- 244000228451 Stevia rebaudiana Species 0.000 claims abstract description 29
- 235000005979 Citrus limon Nutrition 0.000 claims abstract description 26
- 244000131522 Citrus pyriformis Species 0.000 claims abstract description 26
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims abstract description 26
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims abstract description 26
- 235000021014 blueberries Nutrition 0.000 claims abstract description 26
- 241001444063 Aronia Species 0.000 claims abstract description 25
- 235000014360 Punica granatum Nutrition 0.000 claims abstract description 25
- 235000011034 Rubus glaucus Nutrition 0.000 claims abstract description 25
- 235000009122 Rubus idaeus Nutrition 0.000 claims abstract description 25
- 239000012676 herbal extract Substances 0.000 claims abstract description 21
- 239000000796 flavoring agent Substances 0.000 claims abstract description 20
- 240000000851 Vaccinium corymbosum Species 0.000 claims abstract description 19
- 235000019634 flavors Nutrition 0.000 claims abstract description 19
- 240000000249 Morus alba Species 0.000 claims abstract description 18
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 18
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 17
- 240000007651 Rubus glaucus Species 0.000 claims abstract description 17
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 17
- 239000000284 extract Substances 0.000 claims abstract description 17
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 17
- 239000011718 vitamin C Substances 0.000 claims abstract description 17
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 15
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 15
- 235000020708 ginger extract Nutrition 0.000 claims abstract description 14
- 229940002508 ginger extract Drugs 0.000 claims abstract description 14
- 229940094952 green tea extract Drugs 0.000 claims abstract description 14
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 14
- 244000294611 Punica granatum Species 0.000 claims abstract 4
- 102000004190 Enzymes Human genes 0.000 claims description 39
- 108090000790 Enzymes Proteins 0.000 claims description 39
- 238000002156 mixing Methods 0.000 claims description 26
- 239000003963 antioxidant agent Substances 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 17
- 229940069445 licorice extract Drugs 0.000 claims description 13
- 235000006708 antioxidants Nutrition 0.000 claims description 12
- 239000010865 sewage Substances 0.000 claims description 10
- 241000196324 Embryophyta Species 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 238000010298 pulverizing process Methods 0.000 claims description 7
- 239000012267 brine Substances 0.000 claims description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 claims description 3
- 239000008213 purified water Substances 0.000 abstract description 10
- 239000000203 mixture Substances 0.000 abstract description 8
- 239000003673 groundwater Substances 0.000 abstract description 6
- 235000019640 taste Nutrition 0.000 abstract description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 4
- 239000011575 calcium Substances 0.000 abstract description 4
- 229910052791 calcium Inorganic materials 0.000 abstract description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 4
- 239000011707 mineral Substances 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 235000008504 concentrate Nutrition 0.000 abstract 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 3
- 239000011780 sodium chloride Substances 0.000 abstract 3
- 240000008917 Glycyrrhiza uralensis Species 0.000 abstract 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 abstract 1
- 239000006188 syrup Substances 0.000 abstract 1
- 235000020357 syrup Nutrition 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 33
- 241000219991 Lythraceae Species 0.000 description 21
- 230000000694 effects Effects 0.000 description 19
- 238000002835 absorbance Methods 0.000 description 15
- 230000000052 comparative effect Effects 0.000 description 14
- 235000013305 food Nutrition 0.000 description 9
- 244000235659 Rubus idaeus Species 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 244000077233 Vaccinium uliginosum Species 0.000 description 7
- 210000005228 liver tissue Anatomy 0.000 description 7
- 150000008442 polyphenolic compounds Chemical class 0.000 description 7
- 235000013824 polyphenols Nutrition 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 102000016938 Catalase Human genes 0.000 description 6
- 108010053835 Catalase Proteins 0.000 description 6
- 108010054147 Hemoglobins Proteins 0.000 description 6
- 102000001554 Hemoglobins Human genes 0.000 description 6
- 102000019197 Superoxide Dismutase Human genes 0.000 description 6
- 108010012715 Superoxide dismutase Proteins 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 230000002292 Radical scavenging effect Effects 0.000 description 5
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 5
- ZTOJFFHGPLIVKC-CLFAGFIQSA-N abts Chemical compound S/1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C\1=N\N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-CLFAGFIQSA-N 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 235000009200 high fat diet Nutrition 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000013329 compounding Methods 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 229920001542 oligosaccharide Polymers 0.000 description 4
- 150000002482 oligosaccharides Chemical class 0.000 description 4
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 4
- 241000234282 Allium Species 0.000 description 3
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 240000004670 Glycyrrhiza echinata Species 0.000 description 3
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000012055 fruits and vegetables Nutrition 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 235000021590 normal diet Nutrition 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 3
- -1 potassium ferricyanide Chemical compound 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000002000 scavenging effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 240000002234 Allium sativum Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108010053070 Glutathione Disulfide Proteins 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000237502 Ostreidae Species 0.000 description 2
- 241000544066 Stevia Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 238000007259 addition reaction Methods 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 235000004611 garlic Nutrition 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000002438 mitochondrial effect Effects 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 235000020636 oyster Nutrition 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 229940079877 pyrogallol Drugs 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 241000332371 Abutilon x hybridum Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- 238000011814 C57BL/6N mouse Methods 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 108010061951 Methemoglobin Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 240000009164 Petroselinum crispum Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 241000234314 Zingiber Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- OHDRQQURAXLVGJ-AXMZSLBLSA-N azane;(2z)-3-ethyl-2-[(z)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N\N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-AXMZSLBLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000001728 capsicum frutescens Substances 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000007882 dietary composition Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000003044 randomized block design Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001631 vena cava inferior Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/302—Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 항산화 효능이 있고, 기호성이 향상된 식물 혼합 음료의 제조방법 및 이의 제조방법으로 제조된 음료에 관한 것이다. The present invention relates to a method for producing a plant-mixed beverage having antioxidant effect and improved palatability, and to a beverage prepared by the method.
항산화 작용은 체내의 활성산소의 농도를 낮추는 역할을 하는 것으로, 활성산소는 신체에 유발되는 질환의 90%이상의 원인 물질로, 항산화 작용을 통해서 제거해야한다. Antioxidant action is to lower the concentration of free radicals in the body. Active oxygen is the causative agent of more than 90% of diseases induced in the body, and must be removed through antioxidant action.
우리가 먹은 음식물을 에너지로 바꾸기 위해서 산소가 이용되는데, 이때 활성산소가 발생한다. 더욱이 현대인들은 가공된 인스턴트식품들을 즐겨먹는데 이 음식들은 활성산소를 더욱 많이 유발하는 것으로 알려져 있다. 또한 스트레스, 각종 염증성 질환, 주변 환경 등에 따라 많은 활성산소가 발생하게 되고, 노화가 진행될수록 체내 활성산소 제거 능력이 떨어진다.Oxygen is used to convert the food we eat into energy, and at this time, free radicals are generated. Moreover, modern people enjoy eating processed instant foods, which are known to cause more free radicals. In addition, depending on stress, various inflammatory diseases, the surrounding environment, etc., a lot of free radicals are generated, and as aging progresses, the ability to remove free radicals in the body decreases.
활성산소는 유해한 것으로, 이 활성산소는 우리 체내의 세포를 공격하게 되고 노화를 촉진시킨다. 공격으로 손상된 세포는 스스로 세포를 복구하려 하는데 이 과정에서 세포막이 손상되거나 과다하게 커지는 세포가 발생하게 되고, 이로인해 각종 질병이 발생하는 원인이 되기도 한다. Free radicals are harmful, and these free radicals attack cells in our body and accelerate aging. Cells damaged by attack try to repair themselves, but during this process, the cell membrane is damaged or cells that grow excessively are generated, which can cause various diseases.
세포들의 손상을 막고 과다하게 커지지 않고, 정상세포로 복구할 수 있게 하는 항산화 작용을 돕는 식품에는 대표적으로 비타민과 미네랄이 있다. 비타민 C가 다량 함유된 식품으로는 양배추나 파, 고추, 양파, 부르커리, 파슬리, 레몬 등이 있으며, 귤껍질, 양파, 마늘, 시금치와 같은 식품은 비타민 E가 많아 항산화 작용에 도움을 주는 것으로 알려져 있다. 이 외에도 블루베리, 계피, 박하, 레몬유, 로즈마리, 망간, 셀렌 등이 항산화 효과가 우수하다고 알려져 있다. Vitamins and minerals are representative foods that help antioxidant action to prevent damage to cells, prevent excessive growth, and restore normal cells. Foods rich in vitamin C include cabbage, green onion, red pepper, onion, burcurry, parsley, and lemon. Foods such as tangerine peel, onion, garlic, and spinach are rich in vitamin E, which helps antioxidant action. is known In addition, blueberries, cinnamon, mint, lemon oil, rosemary, manganese, and selenium are known to have excellent antioxidant effects.
한편, 최근 생활수준의 향상과 사회구조의 변화와 함께 건강한 식생활에 대한 중요성이 증가하면서 천연물 유래의 건강기능식품과 과일과 채소 등 자연웰빙식품에 대한 관심도 증가하였다. 이처럼 국내 소비자들의 건강에 대한 관심의 증가로 인해 식품선택 패턴이 변하고 있으며 특히 거의 매일 섭취하는 음료에서 강하게 나타나고 있는 추세이다.On the other hand, with the recent improvement in living standards and changes in social structure, as the importance of healthy eating has increased, interest in health functional foods derived from natural products and natural well-being foods such as fruits and vegetables has also increased. As such, food selection patterns are changing due to the growing interest in health among domestic consumers, and this trend is particularly strong in beverages consumed almost every day.
과일 및 야채를 가공하여 제조한 천연주스는 소비자들이 쉽게 섭취할 수 있다는 장점과 함께 유용 폴리페놀 및 다량의 식이 섬유에 의한 장관계 질환 예방, 세포노화억제 및 항산화 효과 등을 나타내는 것으로 알려져 있어 그 소비가 늘어나고 있다.Natural juices manufactured by processing fruits and vegetables are known to have the advantage of being easily ingested by consumers, as well as the prevention of intestinal diseases due to useful polyphenols and a large amount of dietary fiber, as well as the inhibition of cellular aging and antioxidant effects. is increasing
그러나 아직까지 국내에서는 이러한 다양한 과일과 채소를 혼합한 가공식품에 대한 연구가 미비한 실정이다. However, there is still insufficient research on processed foods mixed with these various fruits and vegetables in Korea.
한편, 한국등록특허 제1540515호에 흑도라지, 사과 및 대추 추출물을 유효성분으로 포함하는 항산화 기능성 음료 조성물이 개시되어 있고, 한국등록특허 제1327469호에 항산화 기능성 산마늘 음료 및 그 제조방법이 개시되어 있지만, 본 발명의 깔라만시 농축액, 레몬 농축액, 석류 농축액, 오디청, 라즈베리 농축액, 아로니아 농축액 및 블루베리 농축액을 포함하는, 항산화 효능이 있고, 기호성이 향상된 식물 혼합 음료의 제조방법 및 이의 제조방법으로 제조된 음료에 관해 개시된 바 없다. On the other hand, Korean Patent No. 1540515 discloses an antioxidant functional beverage composition containing black bellflower, apple and jujube extracts as active ingredients, and Korean Patent No. 1327469 discloses an antioxidant functional acid garlic beverage and a method for manufacturing the same. However, the method for producing a plant-mixed beverage with antioxidant effect and improved palatability, including calamansi concentrate, lemon concentrate, pomegranate concentrate, oyster extract, raspberry concentrate, aronia concentrate, and blueberry concentrate of the present invention, and manufacturing method thereof There is no disclosure regarding beverages prepared by the method.
본 발명은 상기와 같은 요구에 의해 도출된 것으로, 깔라만시 농축액, 레몬 농축액, 석류 농축액, 오디청, 라즈베리 농축액, 아로니아 농축액 및 블루베리 농축액을 포함하는 식물 혼합 음료를 제공하고, 상기 식물 혼합 음료가 항산화 효과가 있으며, 소비자 기호성이 향상되는 것을 확인함으로써, 본 발명을 완성하였다.The present invention has been derived from the above needs, and provides a plant mixed beverage comprising calamansi concentrate, lemon concentrate, pomegranate concentrate, oyster extract, raspberry concentrate, aronia concentrate and blueberry concentrate, and the plant mixture By confirming that the beverage has an antioxidant effect and consumer preference is improved, the present invention has been completed.
상기 과제를 해결하기 위하여, 본 발명은 In order to solve the above problems, the present invention
1) 감초 추출물, 녹차 추출물 및 생강 추출물을 혼합한 후, 여과하여 복합 허브 추출물을 획득하는 단계;1) mixing licorice extract, green tea extract and ginger extract, followed by filtration to obtain a complex herbal extract;
2) 스테비아 추출물을 효소처리한 후, 농축시킨 농축액을 분말화하여 효소처리 스테비아를 획득하는 단계; 및2) enzymatically treating the stevia extract, then pulverizing the concentrated concentrate to obtain enzyme-treated stevia; and
3) 물에 상기 단계 1)의 복합 허브 추출물, 단계 2)의 효소처리 스테비아, 깔라만시 농축액, 레몬 농축액, 석류 농축액, 오디청, 라즈베리 농축액, 아로니아 농축액, 블루베리 농축액, 프락토올리고당, 비타민 C 및 깔라만시 향을 혼합하는 단계;를 포함하는 항산화 효능이 있고, 기호성이 향상된 식물 혼합 음료의 제조방법을 제공한다.3) In water, the complex herbal extract of step 1), the enzyme-treated stevia of step 2), calamansi concentrate, lemon concentrate, pomegranate concentrate, mulberry concentrate, raspberry concentrate, aronia concentrate, blueberry concentrate, fructooligosaccharide, It provides a method for producing a blended beverage with antioxidants, including; and mixing vitamin C and calamansi flavor, with improved palatability.
또한, 본 발명은 상기 제조방법으로 제조된 항산화 효능이 있고, 기호성이 향상된 식물 혼합 음료를 제공한다. In addition, the present invention provides a plant-mixed beverage having an antioxidant effect and improved palatability prepared by the above manufacturing method.
본 발명은 항산화 효능이 있고, 기호성이 향상된 식물 혼합 음료의 제조방법 및 이의 제조방법으로 제조된 음료에 관한 것으로, 감초 추출물, 녹차 추출물 및 생강 추출물을 포함하는 복합 허브 추출물, 효소처리 스테비아, 깔라만시 농축액, 레몬 농축액, 석류 농축액, 오디청, 라즈베리 농축액, 아로니아 농축액, 블루베리 농축액, 프락토올리고당, 비타민 C 및 깔라만시 향을 포함하여 제조된 식물 혼합 음료는 ABTs 라디칼 소거활성 및 DPPH 라디칼 소거활성이 우수하고, 총 폴리페놀 함량이 깔라만시 농축액, 레몬 농축액, 석류 농축액, 오디청, 라즈베리 농축액, 아로니아 농축액, 블루베리 농축액에 비해 높으며, 고지방식이에 의해 감소된 적혈구 및 간 조직의 항산화 효소 활성도가 증진되는 것을 확인하였다. 또한, 상기 항산화 효과를 확인한 본 발명의 음료는 이취 및 이미가 나지 않고 소비자들의 기호에 부합한다는 이점이 있다. The present invention relates to a method for producing a mixed beverage with antioxidants and improved palatability and a beverage prepared by the method, and to a complex herbal extract comprising licorice extract, green tea extract and ginger extract, enzyme-treated stevia, and calaman. Botanical blend beverages prepared with Si Concentrate, Lemon Concentrate, Pomegranate Concentrate, Odi Cheong, Raspberry Concentrate, Aronia Concentrate, Blueberry Concentrate, Fructooligosaccharide, Vitamin C and Calamansi Flavor have ABTs radical scavenging activity and DPPH radical It has excellent scavenging activity, and the total polyphenol content is higher than that of calamansi concentrate, lemon concentrate, pomegranate concentrate, mulberry concentrate, raspberry concentrate, aronia concentrate, and blueberry concentrate, and red blood cells and liver tissue reduced by high-fat diet. It was confirmed that the antioxidant enzyme activity of In addition, the beverage of the present invention, which has confirmed the antioxidant effect, has an advantage in that it does not give off odor and image and meets the preferences of consumers.
더욱이 혼합물 추출시, 일반 정제수를 사용하는 것 이외에 염지하수를 추가로 혼합함으로써 고농축 천연 용존 미네랄 및 수용성 칼슘을 음료에 포함할 수 있고, 염지하수의 기능성 물질을 음료에 포함함으로써 손쉽게 섭취할 수 있다는 장점이 있다. Moreover, when extracting the mixture, in addition to using general purified water, highly concentrated natural dissolved minerals and water-soluble calcium can be included in the beverage by additionally mixing salted groundwater, and the functional substance of salted sewage can be easily consumed by including the functional material in the beverage. There is this.
본 발명은 the present invention
1) 감초 추출물, 녹차 추출물 및 생강 추출물을 혼합한 후, 여과하여 복합 허브 추출물을 획득하는 단계;1) mixing licorice extract, green tea extract and ginger extract, followed by filtration to obtain a complex herbal extract;
2) 스테비아 추출물을 효소처리한 후, 농축시킨 농축액을 분말화하여 효소처리 스테비아를 획득하는 단계; 및2) enzymatically treating the stevia extract, then pulverizing the concentrated concentrate to obtain enzyme-treated stevia; and
3) 물에 상기 단계 1)의 복합 허브 추출물, 단계 2)의 효소처리 스테비아, 깔라만시 농축액, 레몬 농축액, 석류 농축액, 오디청, 라즈베리 농축액, 아로니아 농축액, 블루베리 농축액, 프락토올리고당, 비타민 C 및 깔라만시 향을 혼합하는 단계;를 포함하는 항산화 효능이 있고, 기호성이 향상된 식물 혼합 음료의 제조방법에 관한 것이다. 3) In water, the complex herbal extract of step 1), the enzyme-treated stevia of step 2), calamansi concentrate, lemon concentrate, pomegranate concentrate, mulberry concentrate, raspberry concentrate, aronia concentrate, blueberry concentrate, fructooligosaccharide, It relates to a method for producing a mixed beverage with antioxidants and improved palatability, including; mixing vitamin C and calamansi flavor.
상기 단계 1)의 감초, 녹차 및 생강 추출물의 추출 용매는 물, C1~C4의 저급 알코올 또는 이들의 혼합물일 수 있고, 바람직하게는 물을 이용하여 열수 추출하는 것이지만, 이에 한정하는 것은 아니다. The extraction solvent of the licorice, green tea and ginger extract in step 1) may be water, C 1 to C 4 lower alcohol or a mixture thereof, preferably hot water extraction using water, but is not limited thereto. .
상기 단계 1)의 감초, 녹차 및 생강 추출물의 혼합은 감초 추출물 100 중량부에 대하여, 0.2~0.6 중량부의 녹차 추출물 및 0.05~0.15 중량부의 생강 추출물을 혼합하는 것일 수 있고, 바람직하게는 감초 추출물 100 중량부에 대하여, 0.3~0.5 중량부의 녹차 추출물 및 0.08~0.12 중량부의 생강 추출물을 혼합하는 것일 수 있으며, 더 바람직하게는 감초 추출물 100 중량부에 대하여, 0.4 중량부의 녹차 추출물 및 0.1 중량부의 생강 추출물을 혼합하는 것이지만, 이에 한정하는 것은 아니다. The mixing of licorice, green tea and ginger extract in step 1) may be to mix 0.2 to 0.6 parts by weight of green tea extract and 0.05 to 0.15 parts by weight of ginger extract with respect to 100 parts by weight of licorice extract, preferably 100 parts by weight of licorice extract. Based on parts by weight, 0.3 to 0.5 parts by weight of green tea extract and 0.08 to 0.12 parts by weight of ginger extract may be mixed, and more preferably, based on 100 parts by weight of licorice extract, 0.4 parts by weight of green tea extract and 0.1 parts by weight of ginger extract is to mix, but is not limited thereto.
상기 단계 2)의 효소는 당 부가반응을 일으키는 효소는 어느 것이든 사용할 수 있고, 바람직하게는 α-글루코실전이효소를 사용하는 것이지만, 이에 제한되는 것은 아니다. As the enzyme in step 2), any enzyme that causes a sugar addition reaction may be used, and α-glucosyltransferase is preferably used, but is not limited thereto.
상기 단계 3)의 혼합은 물 85~97 중량%에 상기 단계 1)의 복합 허브 추출물 0.01~0.10 중량%, 단계 2)의 효소처리 스테비아 0.02~0.5 중량%, 깔라만시 농축액 0.1~1.5 중량%, 레몬 농축액 0.1~1.0 중량%, 석류 농축액 0.1~1.0 중량%, 오디청 0.8~2.0 중량%, 라즈베리 농축액 0.1~1.0 중량%, 아로니아 농축액 0.1~1.0 중량%, 블루베리 농축액 0.05~0.7 중량%, 프락토올리고당 0.5~5 중량%, 비타민 C 0.1~0.9 중량% 및 깔라만시 향 0.03~0.4 중량%를 혼합하는 것일 수 있고, The mixture of step 3) is 85 to 97% by weight of water, 0.01 to 0.10% by weight of the complex herbal extract of step 1), 0.02 to 0.5% by weight of enzyme-treated stevia of step 2), 0.1 to 1.5% by weight of calamansi concentrate , Lemon concentrate 0.1-1.0% by weight, pomegranate concentrate 0.1-1.0% by weight, Odi Cheong 0.8-2.0% by weight, Raspberry concentrate 0.1-1.0% by weight, Aronia concentrate 0.1-1.0% by weight, Blueberry concentrate 0.05-0.7% by weight , 0.5 to 5% by weight of fructooligosaccharide, 0.1 to 0.9% by weight of vitamin C, and 0.03 to 0.4% by weight of calamansi flavor may be mixed,
바람직하게는 물 90~95 중량%에 상기 단계 1)의 복합 허브 추출물 0.025~0.075 중량%, 단계 2)의 효소처리 스테비아 0.04~0.12 중량%, 깔라만시 농축액 0.25~1.0 중량%, 레몬 농축액 0.2~0.7 중량%, 석류 농축액 0.2~0.7 중량%, 오디청 1~1.5 중량%, 라즈베리 농축액 0.2~0.7 중량%, 아로니아 농축액 0.25~0.9 중량%, 블루베리 농축액 0.1~0.6 중량%, 프락토올리고당 1~3 중량%, 비타민 C 0.2~0.7 중량% 및 깔라만시 향 0.05~0.15 중량%를 혼합하는 것이며, Preferably in 90 to 95 wt% of water, 0.025 to 0.075 wt% of the complex herbal extract of step 1), 0.04 to 0.12 wt% of enzyme-treated stevia in step 2), 0.25 to 1.0 wt% of calamansi concentrate, 0.2 wt% of lemon concentrate ~0.7% by weight, pomegranate concentrate 0.2~0.7% by weight, audi cheong 1-1.5% by weight, raspberry concentrate 0.2~0.7% by weight, aronia concentrate 0.25~0.9% by weight, blueberry concentrate 0.1~0.6% by weight, fructooligosaccharide 1-3% by weight, vitamin C 0.2-0.7% by weight, and calamansi flavor 0.05-0.15% by weight are mixed,
더 바람직하게는 물 93.5 중량%에 상기 단계 1)의 복합 허브 추출물 0.05 중량%, 단계 2)의 효소처리 스테비아 0.08 중량%, 깔라만시 농축액 0.5 중량%, 레몬 농축액 0.45 중량%, 석류 농축액 0.4 중량%, 오디청 1.3 중량%, 라즈베리 농축액 0.4 중량%, 아로니아 농축액 0.5 중량%, 블루베리 농축액 0.3 중량%, 프락토올리고당 2 중량%, 비타민 C 0.4 중량% 및 깔라만시 향 0.1 중량%를 혼합하는 것이지만, 이에 한정하는 것은 아니다. More preferably, in 93.5 wt% of water, 0.05 wt% of the complex herbal extract of step 1), 0.08 wt% of enzyme-treated stevia in step 2), 0.5 wt% of calamansi concentrate, 0.45 wt% of lemon concentrate, 0.4 wt% of pomegranate concentrate %, 1.3% by weight of mulberry, 0.4% by weight of raspberry concentrate, 0.5% by weight of aronia concentrate, 0.3% by weight of blueberry concentrate, 2% by weight of fructooligosaccharide, 0.4% by weight of vitamin C and 0.1% by weight of calamansi flavor but is not limited thereto.
본 발명의 일 구현 예에서, 상기 음료의 당도는 3.5~4.5 브릭스(Brix)일 수 있고, 바람직하게는 4.24 브릭스(Brix)인 것이지만, 이에 한정하는 것은 아니다. In one embodiment of the present invention, the beverage may have a sugar content of 3.5 to 4.5 Brix, preferably 4.24 Brix, but is not limited thereto.
본 발명의 일 구현 예에서, 상기 깔라만시 농축액은 5~9 브릭스(Brix)의 농축액을 사용할 수 있고, 바람직하게는 6~8 브릭스(Brix)의 농축액을 사용하는 것이며, 더 바람직하게는 7 브릭스(Brix)의 농축액을 사용하는 것이지만, 이에 한정하는 것은 아니다. In one embodiment of the present invention, the calamansi concentrate may use a concentration of 5 to 9 Brix, preferably a concentrate of 6 to 8 Brix, more preferably 7 Although the concentrate of Brix is used, it is not limited thereto.
상기 라즈베리 농축액은 55~65 브릭스(Brix)의 농축액을 사용할 수 있고, 바람직하네는 58~62 브릭스(Brix)의 농축액을 사용할 수 있으며, 더 바람직하게는 60 브릭스(Brix)의 농축액을 사용하는 것이지만, 이에 한정하는 것은 아니다. As the raspberry concentrate, a concentrate of 55 to 65 Brix may be used, preferably a concentrate of 58 to 62 Brix may be used, and more preferably a concentrate of 60 Brix is used, but , but is not limited thereto.
상기 아로니아 농축액은 60~70 브릭스(Brix)의 농축액을 사용할 수 있고, 바람직하게는 63~67 브릭스(Brix)의 농축액을 사용하는 것이며, 더 바람직하게는 65 브릭스(Brix)의 농축액을 사용하는 것이지만, 이에 제한되는 것은 아니다. The aronia concentrate may use a 60-70 Brix concentrate, preferably a 63-67 Brix concentrate, and more preferably a 65 Brix concentrate. However, it is not limited thereto.
상기 석류 농축액은 55~65 브릭스(Brix)의 농축액을 사용할 수 있고, 바람직하네는 58~62 브릭스(Brix)의 농축액을 사용할 수 있으며, 더 바람직하게는 60 브릭스(Brix)의 농축액을 사용하는 것이지만, 이에 한정하는 것은 아니다. As the pomegranate concentrate, a concentrate of 55 to 65 Brix may be used, preferably a concentrate of 58 to 62 Brix may be used, and more preferably a concentrate of 60 Brix is used. , but is not limited thereto.
상기 블루베리 농축액은 60~70 브릭스(Brix)의 농축액을 사용할 수 있고, 바람직하게는 63~67 브릭스(Brix)의 농축액을 사용하는 것이며, 더 바람직하게는 65 브릭스(Brix)의 농축액을 사용하는 것이지만, 이에 제한되는 것은 아니다. As the blueberry concentrate, a concentrate of 60 to 70 Brix may be used, preferably a concentrate of 63 to 67 Brix is used, and more preferably a concentrate of 65 Brix is used. However, it is not limited thereto.
레몬 농축액은 60~70 브릭스(Brix)의 농축액을 사용할 수 있고, 바람직하게는 63~67 브릭스(Brix)의 농축액을 사용하는 것이며, 더 바람직하게는 65 브릭스(Brix)의 농축액을 사용하는 것이지만, 이에 제한되는 것은 아니다. As the lemon concentrate, a concentrate of 60 to 70 Brix can be used, preferably a concentrate of 63 to 67 Brix is used, and more preferably a concentrate of 65 Brix is used, However, the present invention is not limited thereto.
오디청은 오디, 황설탕 및 올리고당을 혼합하여 1~5 개월 동안 실온(20±5℃)에서 발효시켜 발효액을 획득하여 사용하는 것일 수 있고, 바람직하게는 오디, 황설탕 및 올리고당을 40~60:25~45:5~25 중량비로 혼합하여 2~4 개월 동안 실온(20±5℃)에서 발효시켜 발효액을 획득하여 사용하는 것이며, 더 바람직하게는 오디, 황설탕 및 올리고당을 50:35:15 중량비로 혼합하여 3 개월 동안 실온(20±5℃)에서 발효시켜 발효액을 획득하여 사용하는 것이지만, 이에 제한되는 것은 아니다. Odicheong may be obtained by mixing mulberry, brown sugar and oligosaccharide and fermenting it at room temperature (20±5℃) for 1 to 5 months to obtain and use a fermented liquid, preferably, 40 to 60 mulberry, brown sugar and oligosaccharide. : 25 ~ 45: 5 ~ 25 weight ratio is mixed and fermented at room temperature (20 ± 5 ℃) for 2 ~ 4 months to obtain and use the fermentation broth, more preferably mulberry, brown sugar and oligosaccharide 50: 35: It is mixed in a weight ratio of 15 and fermented at room temperature (20±5° C.) for 3 months to obtain and use a fermentation broth, but is not limited thereto.
본 발명의 일 구현 예에서, 상기 단계 3)의 물은 순수한 물 또는 염지하수가 혼합된 물을 사용할 수 있고, 바람직하게는 정제수 또는 5~15%(v/v)의 염지하수가 포함된 정제수를 사용할 수 있으며, 더 바람직하게는 10%(v/v)의 염지하수가 포함된 정제수를 사용하는 것이지만, 이에 제한되는 것은 아니다. In one embodiment of the present invention, the water in step 3) may be pure water or water mixed with saltwater, preferably purified water or purified water containing 5-15% (v/v) saltwater. may be used, and more preferably, purified water containing 10% (v/v) salted sewage is used, but is not limited thereto.
본 발명의 용어 '염지하수'는 육지에서 스며든 담수와 바다에서 흘러든 해수가 합쳐져 생성된 것으로, 물속에 녹아있는 염분(鹽分) 등 총 용존 고형물(總溶存固形物)의 함량이 2,000㎎/L 이상인 암반대수층 안의 지하수이다. The term 'saltwater' as used in the present invention is produced by combining fresh water permeated from the land and seawater flowing from the sea, and has a total dissolved solids content such as salt dissolved in the water of 2,000 mg/ It is groundwater in rock aquifers above L.
염지하수는 높은 미네랄 함량을 보이며, 수온은 16~18℃, pH는 7.3~7.5로 저온 안정성과 계절변동 및 특성변화가 적은 물리적 장점이 있으며, 외부환경에 노출되지 않아 일반세균, 중금속 등 유해성분이 없는 청정한 수자원이다. Saltwater has a high mineral content, and the water temperature is 16~18℃ and the pH is 7.3~7.5, so it has low-temperature stability and physical advantages with little seasonal variation and characteristic change. It is not exposed to the external environment, so it is free from harmful components such as general bacteria and heavy metals. There is no clean water resource.
본 발명의 염지하수는 염지하수를 획득할 수 있는 곳이라면 어느 곳이라도 상관 없으나, 바람직하게는 경상북도 울진군에서 획득한 염지하수를 사용하였다. The salt sewage of the present invention may be anywhere as long as it can be obtained. Preferably, salt sewage obtained from Uljin-gun, Gyeongsangbuk-do was used.
본 발명의 일 구현 예에서, 상기 음료의 제조방법은 바람직하게는In one embodiment of the present invention, the method for preparing the beverage is preferably
1) 감초 추출물 100 중량부에 대하여, 0.2~0.6 중량부의 녹차 추출물 및 0.05~0.15 중량부의 생강 추출물을 혼합한 후, 여과하여 복합 허브 추출물을 획득하는 단계;1) with respect to 100 parts by weight of licorice extract, 0.2 to 0.6 parts by weight of green tea extract and 0.05 to 0.15 parts by weight of ginger extract are mixed, followed by filtration to obtain a complex herbal extract;
2) 스테비아 추출물을 α-글루코실전이효소로 효소처리한 후, 농축시킨 농축액을 분말화하여 효소처리 스테비아를 획득하는 단계; 및2) enzymatically treating the stevia extract with α-glucosyltransferase, and then pulverizing the concentrated solution to obtain enzyme-treated stevia; and
3) 물 85~97 중량%에 상기 단계 1)의 복합 허브 추출물 0.01~0.10 중량%, 단계 2)의 효소처리 스테비아 0.02~0.5 중량%, 깔라만시 농축액 0.1~1.5 중량%, 레몬 농축액 0.1~1.0 중량%, 석류 농축액 0.1~1.0 중량%, 오디청 0.8~2.0 중량%, 라즈베리 농축액 0.1~1.0 중량%, 아로니아 농축액 0.1~1.0 중량%, 블루베리 농축액 0.05~0.7 중량%, 프락토올리고당 0.5~5 중량%, 비타민 C 0.1~0.9 중량% 및 깔라만시 향 0.03~0.4 중량%를 혼합하는 단계;를 포함하는 것일 수 있고, 3) 0.01 to 0.10 wt% of the complex herbal extract of step 1) in 85 to 97 wt% of water, 0.02 to 0.5 wt% of enzyme-treated stevia in step 2), 0.1 to 1.5 wt% of calamansi concentrate, 0.1 to lemon concentrate 1.0 wt%, pomegranate concentrate 0.1-1.0 wt%, mulberry 0.8-2.0 wt%, raspberry concentrate 0.1-1.0 wt%, aronia concentrate 0.1-1.0 wt%, blueberry concentrate 0.05-0.7 wt%, fructooligosaccharide 0.5 ~5% by weight, vitamin C 0.1 ~ 0.9% by weight, and the step of mixing 0.03 ~ 0.4% by weight of calamansi flavor; may be to include,
더 바람직하게는 more preferably
1) 감초 추출물 100 중량부에 대하여, 0.2~0.6 중량부의 녹차 추출물 및 0.05~0.15 중량부의 생강 추출물을 혼합한 후, 여과하여 복합 허브 추출물을 획득하는 단계;1) with respect to 100 parts by weight of licorice extract, 0.2 to 0.6 parts by weight of green tea extract and 0.05 to 0.15 parts by weight of ginger extract are mixed, followed by filtration to obtain a complex herbal extract;
2) 스테비아 추출물을 α-글루코실전이효소로 효소처리한 후, 농축시킨 농축액을 분말화하여 효소처리 스테비아를 획득하는 단계; 및2) enzymatically treating the stevia extract with α-glucosyltransferase, and then pulverizing the concentrated solution to obtain enzyme-treated stevia; and
3) 5~15%(v/v)의 염지하수가 포함된 물 90~95 중량%에 상기 단계 1)의 복합 허브 추출물 0.025~0.075 중량%, 단계 2)의 효소처리 스테비아 0.04~0.12 중량%, 깔라만시 농축액 0.25~1.0 중량%, 레몬 농축액 0.2~0.7 중량%, 석류 농축액 0.2~0.7 중량%, 오디청 1~1.5 중량%, 라즈베리 농축액 0.2~0.7 중량%, 아로니아 농축액 0.25~0.9 중량%, 블루베리 농축액 0.1~0.6 중량%, 프락토올리고당 1~3 중량%, 비타민 C 0.2~0.7 중량% 및 깔라만시 향 0.05~0.15 중량%를 혼합하는 단계;를 포함하여 제조될 수 있고, 3) 0.025 to 0.075 wt% of the complex herbal extract of step 1) in 90 to 95 wt% of water containing 5 to 15% (v/v) brine sewage, and 0.04 to 0.12 wt% of stevia enzyme treated in step 2) , calamansi concentrate 0.25-1.0 wt%, lemon concentrate 0.2-0.7 wt%, pomegranate concentrate 0.2-0.7 wt%, mulberry 1-1.5 wt%, raspberry concentrate 0.2-0.7 wt%, aronia concentrate 0.25-0.9 wt% %, blueberry concentrate 0.1-0.6% by weight, fructooligosaccharide 1-3% by weight, vitamin C 0.2-0.7% by weight, and calamansi flavor 0.05-0.15% by weight; mixing;
더욱더 바람직하게는 even more preferably
1) 감초 추출물 100 중량부에 대하여, 0.4 중량부의 녹차 추출물 및 0.1 중량부의 생강 추출물을 혼합한 후, 여과하여 복합 허브 추출물을 획득하는 단계;1) with respect to 100 parts by weight of the licorice extract, 0.4 parts by weight of green tea extract and 0.1 parts by weight of ginger extract are mixed, followed by filtration to obtain a complex herbal extract;
2) 스테비아 추출물을 α-글루코실전이효소로 효소처리한 후, 농축시킨 농축액을 분말화하여 효소처리 스테비아를 획득하는 단계; 및2) enzymatically treating the stevia extract with α-glucosyltransferase, and then pulverizing the concentrated solution to obtain enzyme-treated stevia; and
3) 5~15%(v/v)의 염지하수가 포함된 물 93.5 중량%에 상기 단계 1)의 복합 허브 추출물 0.05 중량%, 단계 2)의 효소처리 스테비아 0.08 중량%, 깔라만시 농축액 0.5 중량%, 레몬 농축액 0.45 중량%, 석류 농축액 0.4 중량%, 오디청 1.3 중량%, 라즈베리 농축액 0.4 중량%, 아로니아 농축액 0.5 중량%, 블루베리 농축액 0.3 중량%, 프락토올리고당 2 중량%, 비타민 C 0.4 중량% 및 깔라만시 향 0.1 중량%를 혼합하는 단계;를 포함하여 제조되는 것이지만, 이에 제한되는 것은 아니다. 3) 0.05 wt% of complex herbal extract of step 1) in 93.5 wt% of water containing 5-15% (v/v) brine sewage, 0.08 wt% of enzyme-treated stevia in step 2), 0.5 wt% of calamansi concentrate % by weight, lemon concentrate 0.45% by weight, pomegranate concentrate 0.4% by weight, mulberry 1.3% by weight, raspberry concentrate 0.4% by weight, aronia concentrate 0.5% by weight, blueberry concentrate 0.3% by weight, fructooligosaccharide 2% by weight, vitamin C Mixing 0.4% by weight and 0.1% by weight of calamansi flavor; is prepared to include, but is not limited thereto.
또한, 본 발명은 상기 제조방법으로 제조된 항산화 효능이 있고, 기호성이 향상된 식물 혼합 음료에 관한 것이다. In addition, the present invention relates to a plant-mixed beverage having an antioxidant effect and improved palatability prepared by the above manufacturing method.
상기 음료는 항산화 효능이 우수하고, 이취 및 이미가 나지 않아 소비자 기호도가 향상되는 효과가 있다. The beverage has excellent antioxidant efficacy, and does not give off odor and image, thereby improving consumer preference.
이하, 제조예 및 실시예를 이용하여 본 발명을 더욱 상세하게 설명하고자 한다. 이들 제조예 및 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 범위가 이들에 의해 제한되지 않는다는 것은 당해 기술분야에서 통상의 지식을 가진 자에게 있어 자명한 것이다. Hereinafter, the present invention will be described in more detail using Preparation Examples and Examples. These preparations and examples are only for illustrating the present invention in more detail, and it will be apparent to those of ordinary skill in the art that the scope of the present invention is not limited thereto.
제조예 1. 배합 재료에 따른 식물 혼합 음료의 제조Preparation Example 1. Preparation of plant-mixed beverage according to compounding materials
하기 표 1에 개시된 바와 같이 재료를 혼합하여 식물 혼합 음료를 제조하였다. A plant-mixed beverage was prepared by mixing the ingredients as shown in Table 1 below.
깔라만시는 기미 및 주근깨 개선효과, 피로회복, 기관지 질환에 도움이 되는 것으로 알려져 있고, 활성산소를 억제하고, 항산화, 항염증, 항암 및 콜레스테롤을 낮추는 것으로 알려져 있으며, 본 발명의 깔라만시 농축액은 7 브릭스(Brix)의 농축액을 사용하였다. Calamansi is known to be helpful for freckle and freckle improvement, fatigue recovery, bronchial disease, inhibits free radicals, antioxidant, anti-inflammatory, anti-cancer and lowers cholesterol, calamansi concentrate of the present invention A concentrated solution of silver 7 Brix was used.
오디는 활성산소를 제거하고, 피부 노화를 방지하고, 시력을 개선하는 효과가 있다고 알려져 있으며, 본 발명의 오디청은 오디, 황설탕, 올리고당을 50:35:15 중량비로 혼합한 후, 실온에서 3개월 동안 발효시킨 다음 발효액만 획득하여 사용하였다. It is known that mulberry is effective in removing active oxygen, preventing skin aging, and improving eyesight. After mixing mulberry, brown sugar, and oligosaccharide in a weight ratio of 50:35:15, mulberry of the present invention is cooled at room temperature. After fermentation for 3 months, only the fermentation broth was obtained and used.
라즈베리는 비타민 C와 안토시아닌을 함유하고 있으며, 피부 미백, 항암, 노화방지, 혈압개선의 효과가 있다고 알려져 있으며, 본 발명의 라즈베리 농축액은 60 브릭스(Brix)의 농축액을 사용하였다. Raspberry contains vitamin C and anthocyanin, and is known to have skin whitening, anti-cancer, anti-aging, and blood pressure improvement effects. The raspberry concentrate of the present invention uses 60 Brix concentrate.
아로니아는 항암, 노화방지, 혈압개선 및 면역력 강화효과가 있다고 알려져 있으며, 본 발명의 아로니아 농축액은 65 브릭스(Brix)의 농축액을 사용하였다. Aronia is known to have anti-cancer, anti-aging, blood pressure improvement and immune-enhancing effects, and 65 Brix concentrate was used for the aronia concentrate of the present invention.
석류는 피부 노화방지, 혈액순환 개선에 효과가 있다고 알려져 있으며, 본 발명의 석류 농축액은 60 브릭스(Brix)의 농축액을 사용하였다. Pomegranate is known to be effective in preventing skin aging and improving blood circulation, and 60 Brix concentrate was used for the pomegranate concentrate of the present invention.
블루베리는 시력개선, 암 순응 촉진, 항궤양 활성 및 항염증 작용이 있다고 알려져 있으며, 본 발명의 블루베리 농축액은 65브릭스(Brix)의 농축액을 사용하였다. Blueberries are known to improve eyesight, promote cancer adaptation, anti-ulcer activity and anti-inflammatory action, and 65 Brix concentrate was used for the blueberry concentrate of the present invention.
레몬은 피부의 콜라겐 합성을 증가시키고, 해독작용을 하는 것으로 알려져 있으며, 본 발명의 레몬 농축액은 65 브릭스(Brix)의 농축액을 사용하였다. Lemon increases collagen synthesis in the skin and is known to have detoxification, and the lemon concentrate of the present invention uses 65 Brix concentrate.
상기 효소처리 스테비아는 스테비아 열수 추출물과 덱스트린을 혼합한 다음 물을 가해 용해한 후, α-글루코실전이효소를 첨가해 당부가반응을 일으킨 다음 효소를 실활시키고, 냉각시킨 반응액을 농축한 다음 건조하여 사용하였다. The enzyme-treated stevia was mixed with stevia hot water extract and dextrin, dissolved by adding water, α-glucosyltransferase was added to cause a sugar addition reaction, the enzyme was inactivated, and the cooled reaction solution was concentrated and dried. was used.
상기 복합허브 추출물은 감초 열수 추출물 100 중량부에 대하여, 0.4 중량부의 녹차 열수 추출물 및 0.1 중량부의 생강 열수 추출물을 혼합한 후, 여과하여 사용하였다. The complex herbal extract was used after mixing 0.4 parts by weight of green tea hot water extract and 0.1 parts by weight of ginger hot water extract with respect to 100 parts by weight of licorice hot water extract, followed by filtration.
상기 실시예 1의 음료는 4.24 브릭스(Brix)의 당도를 나타냈다. The beverage of Example 1 had a sugar content of 4.24 Brix.
제조예 2. 배합비에 따른 식물 혼합 음료의 제조Preparation Example 2. Preparation of a plant-mixed beverage according to the mixing ratio
배합비에 따른 식물 혼합 음료를 하기 표 2에 개시된 바와 같이 혼합하여 제조하였다. Plant mixed drinks according to the mixing ratio were prepared by mixing as disclosed in Table 2 below.
제조예 3. 염지하수를 첨가한 정제수를 이용한 식물 혼합 음료의 제조Preparation Example 3. Preparation of a plant-mixed beverage using purified water to which salted groundwater was added
상기 실험예 1과 동일한 배합으로 식물 혼합 음료를 제조하되, 정제수에 염지하수를 10%(v/v) 포함하여 음료를 제조하였다(실험예 2).A plant-mixed beverage was prepared in the same formulation as in Experimental Example 1, but a beverage was prepared by including 10% (v/v) saltwater in purified water (Experimental Example 2).
본 발명에 사용된 염지하수는 염지하수 1L 당 칼슘이온 1168.7mg, 마그네슘이온 1001mg, 칼륨이온 103.4mg, 나트륨이온 8757.7mg을 포함하고 있다. The salted sewage used in the present invention contains 1168.7 mg of calcium ions, 1001 mg of magnesium ions, 103.4 mg of potassium ions, and 8757.7 mg of sodium ions per 1 L of salted sewage.
염지하수를 첨가한 정제수를 이용하여 음료를 제조한 후, 성분 분석을 의뢰한 결과, 첨가하지 않은 나트륨 및 칼슘이 각각 47.6mg/100ml, 21.4mg/100ml 측정되었으며, 수용성 나트륨과 칼슘은 해양암반수에서 기인된 것으로 추정된다. After preparing a beverage using purified water with added saltwater, as a result of requesting component analysis, sodium and calcium without addition were measured at 47.6mg/100ml and 21.4mg/100ml, respectively, and water-soluble sodium and calcium were found in sea bedrock water. presumed to have originated.
실시예 1. 식물 혼합 음료의 항산화 효과Example 1. Antioxidant effect of plant-mixed beverage
상기 실험예 1 및 배합 원료(깔라만시 농축액, 오디청, 라즈베리 농축액, 아로니아 농축액, 석류 농축액, 블루베리 농축액 및 레몬 농축액)의 항산화 효과를 확인하였다. The antioxidant effect of Experimental Example 1 and the ingredients (calamansi concentrate, mulberry concentrate, raspberry concentrate, aronia concentrate, pomegranate concentrate, blueberry concentrate, and lemon concentrate) was confirmed.
1) One) In vitroin vitro 효능 검증 Efficacy Verification
① 총 폴리페놀 함량① Total polyphenol content
총 폴리페놀 정량은 AOAC에 준하여 정량하였다. 즉 1mg의 시료가 포함된 100㎕의 폴린-시오칼투 페놀 시약에 0.55M Na2CO3 100㎕를 가하여 혼합한 후, 1시간 실온에서 방치하고 750nm에서 흡광도를 측정한 후 표준물질인 탄닌산(tannic acid)으로 작성한 표준곡선의 흡광도 값과 비교하여 폴리페놀 함량을 산출하였다. Total polyphenol quantification was quantified according to AOAC. That is, after adding 100 μl of 0.55 M Na 2 CO 3 to 100 μl of Paulin-Siocaltu phenol reagent containing 1 mg of sample and mixing, it was left at room temperature for 1 hour and absorbance was measured at 750 nm. acid) was compared with the absorbance value of the standard curve prepared to calculate the polyphenol content.
그 결과, 하기 표 3에 개시된 바와 같이 본 발명의 음료는 배합 원료에 비해 총 폴리페놀 함량이 우수하였다. As a result, as shown in Table 3 below, the beverage of the present invention had an excellent total polyphenol content compared to the blended raw material.
원료antioxidant drink
Raw material
② ABTs 라디칼 소거활성② ABTs radical scavenging activity
2.45mM 과황화칼륨(potassium persulfate, P5592, Sigma, USA)에 용해한 7mM ABTs(2,2'-azino-bis[3-ethylbenzothiazoline-6-sulfonicacid] diammoniumsalt; A9941, Sigma, USA)를 실온 및 암소에서 24시간 동안 방치하여 라디칼을 형성시키고, ABTs 용액의 농도는 사용 직전에 734nm에서 흡광도 값이 0.7∼0.9가 되도록 희석하여 실험에 사용하였으며, 준비한 시료 50㎕에 ABTs 용액 100㎕를 첨가하여 10분간 반응시킨 후 734nm에서 흡광도 값을 측정하였다.7 mM ABTs (2,2'-azino-bis[3-ethylbenzothiazoline-6-sulfonicacid] diammoniumsalt; A9941, Sigma, USA) dissolved in 2.45 mM potassium persulfate (P5592, Sigma, USA) at room temperature and in the dark It was left for 24 hours to form radicals, and the concentration of the ABTs solution was diluted so that the absorbance value at 734 nm was 0.7 to 0.9 immediately before use and used for the experiment. The absorbance value was measured at 734 nm after
그 결과, 하기 표 4에 개시된 바와 같이 본 발명의 음료는 배합 원료에 비해 ABTs 소거활성이 우수하였다. As a result, as shown in Table 4 below, the beverage of the present invention had excellent ABTs scavenging activity compared to the blended raw material.
원료antioxidant drink
Raw material
③ DPPH 라디칼 소거활성③ DPPH radical scavenging activity
DPPH 용액의 농도는 사용 직전에 517nm에서 흡광도 값이 0.5∼0.7이 되도록 희석하여 실험에 사용하였으며, 준비한 시료 100㎕에 0.2mM DPPH(1,1-diphenyl-2-picrylhydrazyl, Sigma Cemical Co., USA) 용액 50㎕를 첨가하여 10분간 반응시킨 후 517nm에서 흡광도 값을 측정하였다. The concentration of the DPPH solution was diluted so that the absorbance value at 517 nm was 0.5-0.7 immediately before use, and 0.2 mM DPPH (1,1-diphenyl-2-picrylhydrazyl, Sigma Cemical Co., USA) was added to 100 μl of the prepared sample. ) solution was added and reacted for 10 minutes, and the absorbance value was measured at 517 nm.
그 결과, 하기 표 5에 개시된 바와 같이 본 발명의 음료는 배합 원료에 비해 DPPH 소거활성이 우수하였다. As a result, as shown in Table 5 below, the beverage of the present invention had superior DPPH scavenging activity compared to the blended raw material.
원료antioxidant drink
Raw material
1,000
1,000
2) 2) In vivoin vivo 효능 검증 Efficacy Verification
- 실험동물 및 분류- Experimental animals and classification
생후 5주령의 수컷 C57BL/6N 종을 오리엔트바이오(Gyeonggi-do, Korea)로부터 분양 받아, 1주간 순응시킨 후, 6주령이 되었을 때 난괴법(randomized block design)에 의해 6개의 군으로 나누었다. 사육실의 온도는 22℃, 습도는 55%를 유지하였으며, 6:00시부터 18:00시까지 일광조절을 유지하는 환경에서 사육되었다. 적응기간 동안 동물들의 특이사항을 관찰하여 기록하였으며, 식이와 물은 자유로이 섭취할 수 있도록 하였다. Five-week-old male C57BL/6N species were purchased from Orient Bio (Gyeonggi-do, Korea), acclimatized for one week, and then divided into six groups by randomized block design when they reached six weeks of age. The temperature of the breeding room was 22 ℃, the humidity was 55%, and it was bred in an environment that maintains daylight control from 6:00 to 18:00. During the adaptation period, the animal's peculiarities were observed and recorded, and food and water were freely ingested.
- 실험군 처치방법- How to treat the experimental group
실험동물군은 정상식이군(NC), 고지방식이군(HFC), 실험군 4종, 총 6군으로, 한 그룹당 5마리씩 분류하였다. 정상식이군(Control)은 일반 식이를 급여하였으며, 실험에 사용된 식이는 AIN-76 식이 조성에 준하여 제조하였다. 실험에 사용된 고지방 식이는 60% kcal fat을 포함하는 식이를 사용하였다. 제조된 식이는 4주 동안 공급하였으며 식이와 물은 자유롭게 섭취하도록 공급하였고, 식이 섭취량은 일주일에 2번 측정하였다. Experimental animal groups were classified into 6 groups, including a normal diet group (NC), a high-fat diet group (HFC), and 4 experimental groups, 5 animals per group. The normal diet group (Control) was fed a normal diet, and the diet used in the experiment was prepared according to the AIN-76 dietary composition. The high-fat diet used in the experiment was a diet containing 60% kcal fat. The prepared diet was supplied for 4 weeks, food and water were supplied freely, and food intake was measured twice a week.
항산화 음료인 실험예 1 및 실험예 2는 250mg/kg BW 및 500mg/kg BW 두가지 농도로 급여 하였다. 총 2주 동안 급여한 후, 마취시켜 복부 하대정맥에서 혈액을 채취하였다. 채취한 혈액은 4℃, 3,000rpm에서, 15분간 원심 분리하여 혈청을 분리하였으며, 분리된 혈청으로부터 항산화 효소활성을 측정하였다. 혈액 채취 후, 간 조직을 적출하였고, 적출된 간 조직은 PBS(phosphate buffered saline) 용액에 여러 번 세척하여 표면의 이물질을 제거한 후 칭량한 다음, 즉시 액체 질소에 급냉시킨 후 시료 분석 시까지 -70℃에서 보관하였다. Antioxidant drinks Experimental Example 1 and Experimental Example 2 were fed at two concentrations of 250mg/kg BW and 500mg/kg BW. After feeding for a total of 2 weeks, they were anesthetized and blood was collected from the inferior vena cava. The collected blood was centrifuged at 4° C., 3,000 rpm for 15 minutes to separate serum, and antioxidant enzyme activity was measured from the separated serum. After blood collection, liver tissue was extracted, and the extracted liver tissue was washed several times in PBS (phosphate buffered saline) solution to remove foreign substances on the surface, weighed, and then immediately cooled in liquid nitrogen to -70 until sample analysis. Stored at ℃.
- 항산화 효소 활성도 측정- Measurement of antioxidant enzyme activity
SOD(Superoxide dismutase) 활성도 측정을 위해, 시료 1ml 당 0.8ml 에탄올:클로로포름(3:5, v/v) 용액을 혼합하여 10,000×g에서 원심분리하여 상층액을 획득하였다. 50mM Tris HCl 버퍼(10mM EDTA 함유, pH 8.5) 1.5ml와 7.2mM의 피로갈롤(pyrogallol) 0.1ml을 혼합하여 25℃에서 5분간 미리 반응시킨 후, 상기 획득된 상층액 0.1ml을 첨가하였다. 그 후, 25℃에서 10분간 반응시킨 다음 1N HCl 0.05ml을 가하여 반응 종료시키고, 420nm에서 흡광도를 측정하여 효소활성을 산출하였다. 효소활성의 단위는 효소원을 넣지 않고 반응시킨 7.2mM 피로갈롤 용액의 자동산화를 50% 억제하는 단백질과 헤모글로빈의 양으로 정하였다.For the measurement of SOD (superoxide dismutase) activity, 0.8ml of ethanol:chloroform (3:5, v/v) solution was mixed per 1ml of sample and centrifuged at 10,000×g to obtain a supernatant. After mixing 1.5 ml of 50 mM Tris HCl buffer (containing 10 mM EDTA, pH 8.5) and 0.1 ml of 7.2 mM pyrogallol, pre-reacted at 25° C. for 5 minutes, 0.1 ml of the obtained supernatant was added. Thereafter, after reacting at 25° C. for 10 minutes, 0.05 ml of 1N HCl was added to terminate the reaction, and absorbance was measured at 420 nm to calculate the enzyme activity. The unit of enzyme activity was determined as the amount of protein and hemoglobin that inhibited autoxidation by 50% of a 7.2 mM pyrogallol solution reacted without an enzyme source.
CAT(Catalase) 활성도는 Abei의 방법(1974)으로 측정하였다. 즉, 50mM 인산칼륨 버퍼(potassium phosphate buffer, pH 7.0) 2.89ml에 적혈구 및 간 조직의 미토콘드리아 분획 20㎕를 가하여 25℃에서 5분간 전 반응시켰다. 여기에 기질인 30mM H2O2 100㎕를 넣어 혼합한 즉시 240nm에서 흡광도를 측정하였으며, 이 용액을 다시 시험 튜브에 옮겨 25℃에서 5분간 반응시켜 240nm에서 H2O2 분해에 따른 흡광도의 감소를 측정하였다. H2O2 흡광도 변화와 H2O2 몰흡광계수로 H2O2의 농도를 구한 다음 효소 활성도는 μmol H2O2 감소/분/mg 단백질 또는 헤모글로빈으로 계산하여 나타내었다.Catalase (CAT) activity was measured by Abei's method (1974). That is, 20 μl of the mitochondrial fraction of red blood cells and liver tissue was added to 2.89 ml of 50 mM potassium phosphate buffer (pH 7.0) and pre-reacted at 25° C. for 5 minutes. Absorbance was measured at 240 nm immediately after adding and mixing 100 μl of 30 mM H 2 O 2 as a substrate, and the solution was transferred back to a test tube and reacted at 25° C. for 5 minutes to decrease absorbance due to decomposition of H 2 O 2 at 240 nm was measured. H 2 O 2 Absorbance change and H 2 O 2 Molar extinction coefficient was used to determine the concentration of H 2 O 2 , and then the enzyme activity was calculated as μmol H 2 O 2 decrease/min/mg protein or hemoglobin.
GSH-Px(Glutathione peroxidase) 활성도는 Paglia와 Valentine의 방법(1967)으로 산화형 글루타티온(GSSG)이 GR(glutathion reductase)과 NADPH에 의하여 환원될 때 NADPH의 흡광도가 340nm에서 감소하는 정도를 측정하였다. 즉 0.1M Tris HCl 버퍼(pH 7.2) 2.6ml와 30mM 환원형 글루타티온(GSH) 0.1ml를 넣고 6mM NADPH 용액 0.1ml에 6.25μM H2O2를 넣은 뒤 25℃에서 5분간 전 반응시켰다. 여기에 0.05ml의 사이토졸 분획을 혼합하여 즉시 340nm에서 흡광도를 측정하였고, 이 용액을 다시 시험 튜브에 옮겨 25℃에서 5분간 반응시킨 후 340nm에서 흡광도를 측정하여 NADPH의 분자흡광계수 6.22mM-1cm-1를 이용하여 흡광도의 변화를 계산하였다. 효소활성의 단위는 1분간 1μmol의 산화형 NADPH를 생성하는 효소의 양으로 나타내었다.Glutathione peroxidase (GSH-Px) activity was measured by the method of Paglia and Valentine (1967) to measure the degree to which the absorbance of NADPH decreased at 340 nm when oxidized glutathione (GSSG) was reduced by glutathion reductase (GR) and NADPH. That is, 2.6ml of 0.1M Tris HCl buffer (pH 7.2) and 0.1ml of 30mM reduced glutathione (GSH) were added, and 6.25μM H 2 O 2 was added to 0.1ml of 6mM NADPH solution, followed by reaction at 25° C. for 5 minutes. Herein, 0.05ml of the cytosol fraction was mixed and the absorbance was immediately measured at 340nm, and the solution was transferred back to a test tube and reacted at 25℃ for 5 minutes. Then, the absorbance was measured at 340nm, and the molecular extinction coefficient of NADPH 6.22mM -1 The change in absorbance was calculated using cm -1 . The unit of enzyme activity was expressed as the amount of enzyme that produced 1 μmol of oxidized NADPH per minute.
헤모글로빈 함량 측정은 kit(AM 503-K, 아산제약)를 이용하여 정량하였다. 혈액 중 헤모글로빈은 페리시안화 칼륨과 반응해서 메트헤모글로빈(methemoglobin)으로 전환되고 다시 시안화칼륨과 반응하여 시안메트헤모글로빈(cyanmethemoglobin)으로 전환시킨 후, 이 반응액을 분광광도계 파장 540nm에서 흡광도를 측정하여 헤모글로빈량을 구하였다. 헤모글로빈 측정방법은 먼저 1,000ml 중 페리시안화칼륨 0.2g, 시안화칼륨 0.05g, 인산일칼륨 0.1361g을 함유하는 용액 1ml에 전혈 4㎕를 첨가하여 혼합한 후 실온에서 5분간 반응시켜 발색시킨 후, 1,000ml 중 헤모글로빈 0.64g, 페리시안화칼륨 0.2g, 시안화칼륨 0.05g, 인산일칼륨 0.1361g을 함유하고 있는 표준액을 대조로 하여 파장 550nm에서 흡광도를 측정하였다.Hemoglobin content measurement was quantified using a kit (AM 503-K, Asan Pharmaceutical). Hemoglobin in blood reacts with potassium ferricyanide to be converted to methemoglobin, and then reacts with potassium cyanide to convert to cyanmethemoglobin. was saved. For the hemoglobin measurement method, first, 4 μl of whole blood was added to 1 ml of a solution containing 0.2 g of potassium ferricyanide, 0.05 g of potassium cyanide, and 0.1361 g of monopotassium phosphate in 1,000 ml, followed by reaction at room temperature for 5 minutes to develop color, and then 1,000 ml. The absorbance was measured at a wavelength of 550 nm using a standard solution containing 0.64 g of hemoglobin, 0.2 g of potassium ferricyanide, 0.05 g of potassium cyanide, and 0.1361 g of monopotassium phosphate in ml as a control.
간 조직의 미토콘드리아 및 사이토졸 분획의 단백질 정량은 브래드포드법(1976)으로 BSA(bovine serum albumin)를 표준단백질로 사용하여 정량하였다. Protein quantification of mitochondrial and cytosolic fractions of liver tissue was quantified by the Bradford method (1976) using bovine serum albumin (BSA) as a standard protein.
① 적혈구에서의 항산화 효소 활성도 측정① Measurement of antioxidant enzyme activity in red blood cells
효소 활성도 측정 결과, 하기 표 6에 개시된 바와 같이 고지방식이에 의해 감소되었던 SOD, CAT 및 GSH-Px 활성이 본 발명의 실험예 1 및 실험예 2의 음료를 섭취한 그룹에서 회복되는 것을 확인하였다. As a result of measuring the enzyme activity, it was confirmed that the SOD, CAT and GSH-Px activities, which were reduced by the high-fat diet, were restored in the group that consumed the beverages of Experimental Examples 1 and 2 of the present invention as shown in Table 6 below. .
② 간 조직에서의 항산화 효소 활성도 측정② Measurement of antioxidant enzyme activity in liver tissue
간 조직에서 효소 활성도 측정 결과, 하기 표 7에 개시된 바와 같이 고지방식이에 의해 감소되었던 SOD, CAT 및 GSH-Px 활성이 본 발명의 실험예 1 및 실험예 2의 음료를 섭취한 그룹에서 회복되는 것을 확인하였다. As a result of measuring enzyme activity in liver tissue, as shown in Table 7 below, SOD, CAT, and GSH-Px activities that were reduced by a high-fat diet were recovered in the group that consumed the beverages of Experimental Examples 1 and 2 of the present invention. confirmed that.
실시예 2. 식물 혼합 음료의 관능검사Example 2. Sensory test of plant mixed beverage
본 발명의 식물 혼합 음료의 관능검사는 30~50대 여성 15명 및 남성 15명 총 30명을 대상으로 실시하였다. 맛, 향, 색감, 종합적 기호도에 대한 관능검사는 9점 척도법을 사용하여 진행하였으며, 점수가 높을수록 긍정적 평가를 의미한다.The sensory test of the plant-mixed beverage of the present invention was carried out on a total of 30 people in their 30s and 50s, 15 females and 15 males. The sensory test for taste, aroma, color, and overall preference was conducted using a 9-point scale method, and a higher score means a more positive evaluation.
1) 배합 재료에 따른 식물 혼합 음료1) Plant mixed beverage according to the compounding material
배합 재료에 따른 식물 혼합 음료의 관능검사 결과, 하기 표 8에 개시된 바와 같이 색감의 차이는 실험예 1, 비교예 1 및 비교예 2에서 거의 없었으나, 실험예 1은 맛과 향이 조화롭게 느껴지고, 가벼운 맛이 느껴저 섭취에 부담이 없어, 비교예 1 및 비교예 2에 비해 쉽게 섭취할 수 있었고, 종합 기호도가 가장 현저하였다. As a result of the sensory test of the plant mixed beverage according to the compounding material, as shown in Table 8 below, there was little difference in color in Experimental Example 1, Comparative Example 1 and Comparative Example 2, but Experimental Example 1 felt harmonious in taste and flavor, and was light The taste was felt and there was no burden on intake, and it was easily ingested compared to Comparative Examples 1 and 2, and the overall preference was the most remarkable.
2) 배합비 재료에 따른 식물 혼합 음료2) Plant-mixed beverage according to ingredients
배합비에 따른 식물 혼합 음료의 관능검사 결과, 하기 표 9에 개시된 바와 같이 색감의 차이는 실험예 1, 비교예 3 및 비교예 4에서 거의 없었고, 실험예 1이 비교예 3 및 4에 비해 단맛과 신맛의 조화가 더 우수하고, 향이 연하지도 진하지도 않고 적당하였으며, 이취가 없어 부드럽게 섭취할 수 있었고, 종합 기호도가 가장 우수하였다. As a result of the sensory test of the plant mixed beverage according to the compounding ratio, as shown in Table 9 below, there was almost no difference in color in Experimental Example 1, Comparative Example 3 and Comparative Example 4, and Experimental Example 1 was sweeter and sweeter than Comparative Examples 3 and 4 The harmony of sour taste was better, the flavor was moderate, neither mild nor strong, and there was no off-flavor, so it could be consumed gently, and the overall preference was the best.
또한, 실험예 1과 염지하수가 첨가된 실험예 2는 종합적 기호도에 차이가 없었다. In addition, there was no difference in overall acceptance between Experimental Example 1 and Experimental Example 2 to which salted sewage was added.
Claims (6)
2) 스테비아 추출물을 효소처리한 후, 농축시킨 농축액을 분말화하여 효소처리 스테비아를 획득하는 단계; 및
3) 물에 상기 단계 1)의 복합 허브 추출물, 단계 2)의 효소처리 스테비아, 깔라만시 농축액, 레몬 농축액, 석류 농축액, 오디청, 라즈베리 농축액, 아로니아 농축액, 블루베리 농축액, 프락토올리고당, 비타민 C 및 깔라만시 향을 혼합하는 단계;를 포함하는 항산화 효능이 있고, 기호성이 향상된 식물 혼합 음료의 제조방법.1) mixing licorice extract, green tea extract and ginger extract, followed by filtration to obtain a complex herbal extract;
2) enzymatically treating the stevia extract, then pulverizing the concentrated solution to obtain enzyme-treated stevia; and
3) In water, the complex herbal extract of step 1), the enzyme-treated stevia of step 2), calamansi concentrate, lemon concentrate, pomegranate concentrate, mulberry concentrate, raspberry concentrate, aronia concentrate, blueberry concentrate, fructooligosaccharide, Mixing vitamin C and calamansi flavor; has an antioxidant effect, including; and a method for producing a plant-mixed beverage with improved palatability.
1) 감초 추출물 100 중량부에 대하여, 0.2~0.6 중량부의 녹차 추출물 및 0.05~0.15 중량부의 생강 추출물을 혼합한 후, 여과하여 복합 허브 추출물을 획득하는 단계;
2) 스테비아 추출물을 α-글루코실전이효소로 효소처리한 후, 농축시킨 농축액을 분말화하여 효소처리 스테비아를 획득하는 단계; 및
3) 5~15%(v/v)의 염지하수가 포함된 물 90~95 중량%에 상기 단계 1)의 복합 허브 추출물 0.025~0.075 중량%, 단계 2)의 효소처리 스테비아 0.04~0.12 중량%, 깔라만시 농축액 0.25~1.0 중량%, 레몬 농축액 0.2~0.7 중량%, 석류 농축액 0.2~0.7 중량%, 오디청 1~1.5 중량%, 라즈베리 농축액 0.2~0.7 중량%, 아로니아 농축액 0.25~0.9 중량%, 블루베리 농축액 0.1~0.6 중량%, 프락토올리고당 1~3 중량%, 비타민 C 0.2~0.7 중량% 및 깔라만시 향 0.05~0.15 중량%를 혼합하는 단계;를 포함하는 것을 특징으로 하는 항산화 효능이 있고, 기호성이 향상된 식물 혼합 음료의 제조방법.According to claim 1,
1) with respect to 100 parts by weight of the licorice extract, 0.2 to 0.6 parts by weight of green tea extract and 0.05 to 0.15 parts by weight of ginger extract are mixed, followed by filtration to obtain a complex herbal extract;
2) enzymatically treating the stevia extract with α-glucosyltransferase, and then pulverizing the concentrated solution to obtain enzyme-treated stevia; and
3) 0.025 to 0.075 wt% of the complex herbal extract of step 1) in 90 to 95 wt% of water containing 5 to 15% (v/v) brine sewage, and 0.04 to 0.12 wt% of stevia enzyme treated in step 2) , calamansi concentrate 0.25-1.0 wt%, lemon concentrate 0.2-0.7 wt%, pomegranate concentrate 0.2-0.7 wt%, mulberry 1-1.5 wt%, raspberry concentrate 0.2-0.7 wt%, aronia concentrate 0.25-0.9 wt% %, blueberry concentrate 0.1-0.6% by weight, fructooligosaccharide 1-3% by weight, vitamin C 0.2-0.7% by weight, and calamansi flavor 0.05-0.15% by weight; mixing; A method for producing a plant-mixed beverage with improved efficacy and palatability.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190164083A KR102294393B1 (en) | 2019-12-10 | 2019-12-10 | Manufacturing method of plant-mixed beverage with antioxidant property and improved palatability and beverage produced by the same method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190164083A KR102294393B1 (en) | 2019-12-10 | 2019-12-10 | Manufacturing method of plant-mixed beverage with antioxidant property and improved palatability and beverage produced by the same method |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20210073342A true KR20210073342A (en) | 2021-06-18 |
KR102294393B1 KR102294393B1 (en) | 2021-08-27 |
Family
ID=76623511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190164083A KR102294393B1 (en) | 2019-12-10 | 2019-12-10 | Manufacturing method of plant-mixed beverage with antioxidant property and improved palatability and beverage produced by the same method |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102294393B1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101543569B1 (en) * | 2015-01-30 | 2015-08-13 | 농업회사법인 건강한사람들 주식회사 | Stabilizing method of natural extract comprising anthocyanin using calamansi |
KR20160101578A (en) * | 2015-02-17 | 2016-08-25 | 한림대학교 산학협력단 | Functional health food composition and mathod for manufacturing the same |
KR20170073778A (en) * | 2015-12-18 | 2017-06-29 | (주)오복야시골가자농업회사법인 | High concentration berry beverage with anti-oxidative activity and manufacturing method thereby |
-
2019
- 2019-12-10 KR KR1020190164083A patent/KR102294393B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101543569B1 (en) * | 2015-01-30 | 2015-08-13 | 농업회사법인 건강한사람들 주식회사 | Stabilizing method of natural extract comprising anthocyanin using calamansi |
KR20160101578A (en) * | 2015-02-17 | 2016-08-25 | 한림대학교 산학협력단 | Functional health food composition and mathod for manufacturing the same |
KR20170073778A (en) * | 2015-12-18 | 2017-06-29 | (주)오복야시골가자농업회사법인 | High concentration berry beverage with anti-oxidative activity and manufacturing method thereby |
Also Published As
Publication number | Publication date |
---|---|
KR102294393B1 (en) | 2021-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Peñas et al. | Se improves indole glucosinolate hydrolysis products content, Se-methylselenocysteine content, antioxidant capacity and potential anti-inflammatory properties of sauerkraut | |
KR101301094B1 (en) | Composition for relieving hangover or improving liver function | |
KR101183605B1 (en) | The beverage composition for anti-hangover functional using cucumber vinegar | |
US20050163880A1 (en) | Method of preparing kakadu plum powder | |
KR101541516B1 (en) | Mathod Manufacturing lON Mineral Using Silk worm, Muberry leaf, and Muberry twig And Health Drink Manufactured by this | |
KR101793933B1 (en) | Functional Gochujang Having Antioxidant Activity and Whitening Effects and Manufacturing Method Thereof | |
KR101670649B1 (en) | A method for preparation of mixed composition with fermented medical plants extracts | |
KR101984400B1 (en) | Process for producing antioxidant and anti-fatigue efficacy of mulberry vinegar | |
KR102127411B1 (en) | Composition comprising natural complex extract for protecting liver and relieving hangover | |
KR101838576B1 (en) | Fermented Lespedeza cuneata extract and its manufacturing method and drink containing it | |
KR102294393B1 (en) | Manufacturing method of plant-mixed beverage with antioxidant property and improved palatability and beverage produced by the same method | |
KR20100081459A (en) | Red pepper from paste garlic and sea tangle and a method for producing the red pepper | |
KR102433586B1 (en) | Food composition for relieving hangover and improving hepatic function | |
KR101672098B1 (en) | Composition for removing hangover comprising fermented rice rinse water | |
KR101043807B1 (en) | A functional salt and a method of preparing the same | |
KR20200131555A (en) | Composition for health functional beverage and manufacturing method thereof | |
KR100789399B1 (en) | Health Beverage composition containing the extract of Laminaria sp. Gelidium sp. and Grateloupia sp. | |
Yitayal et al. | Nutritional Value of Coffee Made from a Mixture of Coffee Leaf and Spices Used in Ethiopia | |
KR100541065B1 (en) | Beverage using astringent coat of chestnut | |
KR20180129579A (en) | Onion Coat composition Using An Enzyme With Stevia Extract And Method thereof | |
KR102365198B1 (en) | Facturing method of functional liquefied healthfoods using Gastroia elata Blume, Polygonum multiflorum Thunberg and mountain ginseng | |
KR20100042193A (en) | Alcohol detoxification composition used matured dried persimmon | |
KR101864833B1 (en) | Method for producing Lentinula edodes mixed tea beverage and Lentinula edodes mixed tea beverage produced by the same method | |
KR100505764B1 (en) | Hangover curing agent containing astaxanthin, aspartic acid and extract from flowers of an arrowroot | |
Yıldırım | Compositional, Nutritional and Therapeutic Values of Wine and Toxicology |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right |